NCT07176585Completed
A Prospective, Single-site, Single-group Value Study on the Diagnosis of Functional Myocardial Ischemia Based on IVUS Plaque Characteristics
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
This study aims to evaluate the accuracy of IVUS-calculated percent atheroma volume (PAV) for diagnosing functional myocardial ischemia, using FFR as the gold standard.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 105 (actual)
- First submitted
- 1 Sept 2025
- Start date
- 23 Sept 2025
- Primary completion date
- 4 Jan 2026
- Lead sponsor
- Insight Lifetech Co., Ltd.
- Diseases
- Coronary artery disease
- NCT number
- NCT07176585
What you commit to
- Study type: Observational
- Participants enrolled: 105
- From 23 Sept 2025 to the primary completion date, 4 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Study participants are currently participating in other drug or device clinical studies and have not achieved the study endpoints;
Other
- STEMI as clinical presentation within 7 days;
- Chronic Total Occlusion (CTO) as target vessel;
- Significant contraindication to adenosine administration (e.g., atrioventricular block, severe asthma, etc.);
- Pregnant or nursing;
- Other situations considered by the investigator as unsuitable for participation in this study.
Who the study is looking for
- Study participants must be at least 18 years of age and younger than 80 years of age, regardless of gender;
- Stable coronary artery disease, unstable angina, or acute myocardial infarction (AMI ≥ 7 days);
- Coronary angiography showed primary lesions with a visual stenosis of 30% to 90% in at least two coronary arteries ≥ 2.5 mm in diameter;
- Willing to participate in the study and able to understand, read, and sign the informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fuwai Hospital ，CAMS&PUMC Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.